ADCES MTT EP 1 | Talk to Me About Dual Agonists

Estimated Time
0.5 hr

Release Date
Sep 12, 2022

Expiration Date
Sep 11, 2023

ACTIVITY DESCRIPTION

For prescribers and non-prescribers alike, therapeutic inertia can be a big challenge when trying to optimize therapy to control patients’ glucose levels and improve their overall health. Such obstacles can be even more difficult when trying to switch treatment regimens. Novel therapies can be miracles, but only if patients can actually get them. In Talk to Me About Dual Agonists, episode 1 of the Med Table TalkTM series, certified diabetes care and education specialists address therapeutic inertia and the need to treat the whole person, rather than just A1C. They then explain the mechanisms of action, efficacy and safety, and precautions for using a unimolecular dual agonist and strategies for helping patients gain access.

Speakers

Accreditation and Disclosure Information

TARGET AUDIENCE
This CE Activity is intended for nurses, dietitians, pharmacists, PAs, and physicians that care for the person with diabetes.

EDUCATIONAL OBJECTIVES
After completing this CE activity, the participant should be better able to:

  • Relate the pathophysiology of GLP-1 and GIP to potential benefits of agonism of multiple receptors that affect energy homeostasis and the MOA of novel therapies 
  • Interpret the clinical implications of the efficacy and safety data of novel dual agonists for T2D 

AGENDA

  • Welcome, introductions, rationale
  • New approaches to manage weight and glucose levels with dual agonists: clinical implications of the mechanism of action and safety and efficacy data
  • Characteristics of ideal candidates
  • Case vignettes including social determinants of health
  • Q&A
  • Post test and evaluation

ACCREDITATION, SUPPORT, AND CREDIT

JA Logo

 

In support of improving patient care, this activity has been planned by Medical Learning Institute, Inc. Medical Learning Institute, Inc. is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team

 

IPCE

 

This activity was planned by and for the healthcare team, and learners will receive 0.5 Interprofessional Continuing Education (IPCE) credits for learning and change.

 

Physician Continuing Medical Education
Medical Learning Institute, Inc. (MLI) designates this enduring material for a maximum of 0.5 AMA PRA Category 1 CreditTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nursing Continuing Professional Development
Successful complete of this nursing continuing professional development activity will be awarded 0.5 contact hour and 0.15 contact hour in the area of pharmacology.

Continuing Pharmacy Education
Medical Learning Institute, Inc. designates this continuing education activity for 0.5 contact hour (0.05 CEU) of the Accreditation Council for Pharmacy Education.

Universal Activity Number: JA0007322-0000-22-097-H01-P
Type of Activity: Knowledge

AAPA Credit Designation Statement

AAPA LogoMedical Learning Institute, Inc. has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 0.5 AAPA Category 1 CME credit. Approval is valid until 09/11/2023. PAs should only claim credit commensurate with the extent of their participation. 

 

Dietitian Continuing Professional Education Units (CPEUs)
CDR LogoCompletion of this RD/DTR profession-specific or IPCE activity awards CPEUs (One IPCE credit = One CPEU).
If the activity is dietetics-related but not targeted to RDs or DTRs, CPEUs may be claimed which are commensurate with participation in contact hours (One 60 minute hour = 1 CPEU).
RD’s and DTRs are to select activity type 102 in their Activity Log. Performance Indicator selection is at the learner’s discretion.

 

Medical Learning Institute, Inc. is a Continuing Professional Education (CPE) Accredited provider with the Commission on Dietetic Registration (CDR). 

CDR Credentialed Practitioners will receive 0.5 Continuing Professional Education Units (CPEUs) for completion of this activity/material.

SUPPORT STATEMENT
This activity is supported by an educational grant from Lilly.

DISCLOSURE & CONFLICT OF INTEREST POLICY
Medical Learning Institute, Inc., is committed to providing high quality continuing education to healthcare professionals, as individuals and teams, with a protected space to learn, teach, and engage in scientific discourse free from influence from ineligible companies that may have an incentive to insert commercial bias into education.  To that end, MLI requires faculty, presenters, planners, staff, and other individuals who are in a position to control the content of this CE activity to disclose all financial relationships they have had in the past 24 months with ineligible companies as defined by the ACCME, as related to the content of this CE activity, regardless of the amount or their view of the relevance to the education. All identified COI will be thoroughly vetted and mitigated according to MLI policy. These disclosures will be provided to learners prior to the start of the CE activity. 

FACULTY DISCLOSURES

Planner/Presenter
Kathy B. Doane, PharmD, RPh, CMTM, BC-ADM, CDCES, RDN, Clinical Pharmacist Specialist and Diabetes Educator, Caring Health Center, Springfield, MA
Kathy B. Doane, PharmD, RPh, CMTM, BC-ADM, CDCES, RDN has no relevant financial relationships with ineligible companies to disclose for this educational activity.  

Planner/Presenter
Kimberly D. Ellis, MSN, FNP-C, CDCES, Founder, Ellis Diabetes Education & Consulting LLC, Dallas, TX
Kimberly D. Ellis, MSN, FNP-C, CDCE has no relevant financial relationships with ineligible companies to disclose for this educational activity.  

Planner/Presenter
Adrienne Maye, RN, BSN, CDCES, Certified Diabetes Care and Education Specialist, Founder and Owner, Moving Forward with Diabetes Management, LLC, Dallas, GA
Adrienne Maye, RN, BSN, CDCES has no relevant financial relationships with ineligible companies to disclose for this educational activity.  

Guest Speaker
Jennifer Goldman, PharmD, CDCES, BC-ADM, FCCP, Professor of Pharmacy Practice, Clinical Pharmacist, Well Life, Massachusetts College of Pharmacy and Health Sciences, Boston, MA
Jennifer Goldman, PharmD, CDCES, BC-ADM, FCCP, has a financial interest/relationship or affiliation in the form of:
Speakers’ Bureau with Abbott Diabetes, Amarin, Boehringer Ingelheim, Lilly, Novo Nordisk, and Xeris.
The following relationships have ended within the last 24 months:
Advisory Board/Consultant for and Speakers’ Bureau with Sanofi.

PLANNING COMMITTEE AND CONTENT/PEER REVIEWERS
The planners and content/peer reviewers from Medical Learning Institute, Inc., the accredited provider, do not have any relevant financial relationships to disclose with ineligible companies unless listed below.

All of the relevant financial relationships of individuals for this activity have been mitigated.

DISCLOSURE OF UNLABELED USE 
This educational activity may contain discussions of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this CE activity do not recommend the use of any agent outside of the labeled indications. The opinions expressed in the CE activity are those of the presenters and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

DISCLAIMER 
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this CE activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this CE activity should not be used by clinicians without evaluation of their patient's conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer's product information, and comparison with recommendations of other authorities.

METHOD OF PARTICIPATION
There are no fees for participating in or receiving credit for this CE activity. In order to receive credit, learners must participate in the entire CE activity, complete the post-test and activity evaluation form and your certificate of credit will be generated. A passing score of 70% or higher is needed to obtain credit.  Once submitted, the certificate will be automatically generated as a PDF online.

For information on applicability and acceptance of continuing education credit for this activity, please consult your professional licensing board.

If you have questions regarding your certificate, please contact Marissa Grossman via email at mgrossman@mlieducation.org.

ABOUT THIS ACTIVITY
Medical Learning Institute, Inc. is responsible for the selection of this activity’s topics, the preparation of editorial content, and the distribution of this CE activity. Our activities may contain references to unapproved products or uses of these products in certain jurisdictions. The preparation of this activity is supported by educational grants subject to written agreements that clearly stipulate and enforce the editorial independence of Medical Learning Institute, Inc.

The materials presented here are used with the permission of the authors and/or other sources. These materials do not necessarily reflect the views of Medical Learning Institute, Inc., or any of its partners, providers, and/or supporters.